# Terminology — Mark Twain

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

## Diagnoses

| Use | System | Code | Display | Evidence |
|---|---|---|---|---|
| Presenting problem, resolved at the consultation | ICD-10-CM FY2026 | Z63.4 | Disappearance and death of family member | S; linked to his wife's documented death |
| Active problem, from the consultation | ICD-10-CM FY2026 | F43.81 | Prolonged grief disorder | S; linked to his documented bereavements |
| Active problem | ICD-10-CM FY2026 | F17.290 | Nicotine dependence, other tobacco product, uncomplicated | S; linked to his documented cigar smoking |
| Presenting symptom, resolved at five weeks | ICD-10-CM FY2026 | R07.89 | Other chest pain | S |
| Active problem, from five weeks | ICD-10-CM FY2026 | I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | S |
| Active problem | ICD-10-CM FY2026 | M10.9 | Gout, unspecified | S; linked to his documented gout |
| Sick visit, resolved | ICD-10-CM FY2026 | J20.9 | Acute bronchitis, unspecified | S |

No major depressive disorder, bipolar disorder or other mood disorder code is used; see the editorial resolutions in sources.md. Cigar use is coded as another tobacco product (F17.29-).

## Medications (RxNorm)

| Code | Display |
|---|---|
| 636671 | varenicline 0.5 MG Oral Tablet (first week) |
| 636676 | varenicline 1 MG Oral Tablet |
| 617311 | atorvastatin 40 MG Oral Tablet |
| 308416 | aspirin 81 MG Delayed Release Oral Tablet |
| 197319 | allopurinol 100 MG Oral Tablet (100 mg, then 200 mg as two tablets) |
| 197320 | allopurinol 300 MG Oral Tablet |
| 197541 | colchicine 0.6 MG Oral Tablet |
| 312615 | prednisone 20 MG Oral Tablet (five-day flare course, prescribed while he was away) |

No antidepressant, benzodiazepine, Z-drug, sedating antihistamine, decongestant or antibiotic is prescribed; the reasons are recorded in the notes.

## Results (LOINC 2.81)

| Code | Measure | Unit | Category |
|---|---|---|---|
| 6690-2, 718-7, 777-3 | White cells, hemoglobin, platelets | 10*3/uL, g/dL | laboratory |
| 51990-0 | Basic metabolic panel (organizer) | — | panel |
| 2951-2, 2823-3, 2160-0, 98979-8, 2345-7 | Sodium, potassium, creatinine, eGFR (CKD-EPI 2021), glucose | mmol/L, mg/dL, mL/min/{1.73_m2} | laboratory |
| 1742-6 | ALT | U/L | laboratory |
| 3084-1 | Urate | mg/dL | laboratory |
| 4548-4 | Hemoglobin A1c | % | laboratory |
| 2093-3, 2085-9, 13457-7, 2571-8 | Total cholesterol, HDL, LDL (calculated), triglycerides | mg/dL | laboratory |
| 3016-3, 2132-9 | TSH, vitamin B12 | m[IU]/L, pg/mL | laboratory |
| 44261-6 | PHQ-9 total score | {score} | survey |
| 55758-7 | PHQ-2 total score | {score} | survey |
| 75626-2 | AUDIT-C total score | {score} | survey |
| 72233-0 | Mini-Cog total score | {score} | survey |

Reference ranges are typical adult male ranges chosen for the teaching record; interpretation flags follow them. The PG-13-R has no LOINC code and is recorded as narrative (see sources.md). The stool immunochemical test, hepatitis C antibody, abdominal aortic ultrasound, Timed Up and Go and CT coronary angiography findings are also recorded as narrative.

## Procedures, immunizations, and encounter types

- Procedures: SNOMED CT 29303009 (electrocardiographic procedure), 419545005 (CT angiography of coronary artery with contrast) and 713603004 (advance care planning).
- Encounter types: SNOMED CT 390906007 (follow-up encounter) for the four focused chronic-care visits, 281038008 (geriatric annual health check) for the subsequent annual wellness visit, and 185345009 (encounter for symptom) for the sick visit. The services are named in plain text as HCPCS G0439 and CPT 99497; neither is used as a coded value.
- Immunizations: CVX 135 (influenza, high-dose), 216 (PCV20), 305 (RSV, bivalent RSVpreF) and 187 (zoster recombinant).
- No known allergy: SNOMED CT 716186003.

## Vital signs

The seven visits use LOINC 8302-2, 29463-7, 39156-5, 8480-6, 8462-4, 8867-4, 9279-1, 8310-5, and 59408-5 with UCUM units.

## Review note

Codes were checked against the public terminology server and NLM RxNav on November 5, 2026. They do not imply that Mark Twain received these diagnoses, tests, or medications during his lifetime.
